Cambridge Trust’s Sotera Health SHC Stock Holding History

Cambridge Trust’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26	Closed	-$1K	–	1128
2021 Q4	$1K	Buy	+26	New	+$622	﹤0.01%	1023

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Cambridge Trust's SHC Position: Q1 2022 in Review

Cambridge Trust sold out of Sotera Health (SHC) in Q1 2022, closing a stake of 26 shares — an estimated $1K sold.

Cambridge Trust first reported a position in SHC in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 147 funds tracked by Wall St. Rank hold SHC as of Q1 2022.

Cambridge Trust reported no remaining Sotera Health position as of Q1 2022 after selling out during the quarter.
Cambridge Trust sold 26 Sotera Health shares in Q1 2022, an estimated $1K.
Cambridge Trust first reported a position in Sotera Health in Q4 2021 and held it in 1 quarter.
Cambridge Trust's Sotera Health position peaked at $1K in Q4 2021.
147 funds tracked by Wall St. Rank held Sotera Health as of Q1 2022.

Based on Cambridge Trust's 13F filing for Q1 2022, filed 12 May 2022.